These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12543948)

  • 1. Gene therapy. Seeking the cause of induced leukemias in X-SCID trial.
    Kaiser J
    Science; 2003 Jan; 299(5606):495. PubMed ID: 12543948
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene therapy. Second child in French trial is found to have leukemia.
    Marshall E
    Science; 2003 Jan; 299(5605):320. PubMed ID: 12531981
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene therapy resumes.
    Novak K
    Nat Rev Cancer; 2002 Nov; 2(11):813. PubMed ID: 12442759
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene therapy. RAC's advice: proceed with caution.
    Kaiser J
    Science; 2002 Dec; 298(5601):2113-5. PubMed ID: 12481114
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer fears cast doubts on future of gene therapy.
    Check E
    Nature; 2003 Feb; 421(6924):678. PubMed ID: 12610583
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene therapy. Panel urges limits on X-SCID trials.
    Kaiser J
    Science; 2005 Mar; 307(5715):1544-5. PubMed ID: 15761128
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene therapy. RAC hears a plea for resuming trials, despite cancer risk.
    Kaiser J
    Science; 2003 Feb; 299(5609):991. PubMed ID: 12586909
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene therapy. As Gelsinger case ends, gene therapy suffers another blow.
    Couzin J; Kaiser J
    Science; 2005 Feb; 307(5712):1028. PubMed ID: 15718439
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulators split on gene therapy as patient shows signs of cancer.
    Check E
    Nature; 2002 Oct; 419(6907):545-6. PubMed ID: 12374936
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene therapy. What to do when clear success comes with an unclear risk?
    Marshall E
    Science; 2002 Oct; 298(5593):510-1. PubMed ID: 12386304
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency.
    McCormack MP; Rabbitts TH
    N Engl J Med; 2004 Feb; 350(9):913-22. PubMed ID: 14985489
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene therapists hopeful as trials resume with childhood disease.
    Check E
    Nature; 2004 Jun; 429(6992):587. PubMed ID: 15190314
    [No Abstract]   [Full Text] [Related]  

  • 13. Medicine. Gene therapy--new challenges ahead.
    Williams DA; Baum C
    Science; 2003 Oct; 302(5644):400-1. PubMed ID: 14563994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. US panel advises resumption of gene trials.
    Fox JL
    Nat Biotechnol; 2002 Nov; 20(11):1068-9. PubMed ID: 12410240
    [No Abstract]   [Full Text] [Related]  

  • 15. Occurrence of leukaemia following gene therapy of X-linked SCID.
    Kohn DB; Sadelain M; Glorioso JC
    Nat Rev Cancer; 2003 Jul; 3(7):477-88. PubMed ID: 12835668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second cancer case halts gene-therapy trials.
    Check E
    Nature; 2003 Jan; 421(6921):305. PubMed ID: 12540867
    [No Abstract]   [Full Text] [Related]  

  • 17. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.
    Hacein-Bey-Abina S; Von Kalle C; Schmidt M; McCormack MP; Wulffraat N; Leboulch P; Lim A; Osborne CS; Pawliuk R; Morillon E; Sorensen R; Forster A; Fraser P; Cohen JI; de Saint Basile G; Alexander I; Wintergerst U; Frebourg T; Aurias A; Stoppa-Lyonnet D; Romana S; Radford-Weiss I; Gross F; Valensi F; Delabesse E; Macintyre E; Sigaux F; Soulier J; Leiva LE; Wissler M; Prinz C; Rabbitts TH; Le Deist F; Fischer A; Cavazzana-Calvo M
    Science; 2003 Oct; 302(5644):415-9. PubMed ID: 14564000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer risk prompts US to curb gene therapy.
    Check E
    Nature; 2003 Mar; 422(6927):7. PubMed ID: 12621402
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene therapy insertional mutagenesis insights.
    Davé UP; Jenkins NA; Copeland NG
    Science; 2004 Jan; 303(5656):333. PubMed ID: 14726584
    [No Abstract]   [Full Text] [Related]  

  • 20. Safeguards for gene therapy trials.
    FDA Consum; 2003; 37(3):5. PubMed ID: 12793378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.